Skip to main content
. 2019 Jul 4;12:68. doi: 10.1186/s13045-019-0751-4

Table 3.

Multivariate analysis for relapse incidence after haplo-SCT for ALL and AML

graphic file with name 13045_2019_751_Tab3_HTML.jpg

ALL acute lymphoblastic leukemia, AML acute myeloid leukemia, RI relapse incidence, HR hazard ratio, SCT stem cell transplant, CR complete remission, HCT-CI hematopoietic cell transplantation comorbidity index, CMV cytomegalovirus